Does NILOTINIB Cause Therapy non-responder? 167 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 167 reports of Therapy non-responder have been filed in association with NILOTINIB (nilotinib). This represents 0.7% of all adverse event reports for NILOTINIB.
167
Reports of Therapy non-responder with NILOTINIB
0.7%
of all NILOTINIB reports
23
Deaths
18
Hospitalizations
How Dangerous Is Therapy non-responder From NILOTINIB?
Of the 167 reports, 23 (13.8%) resulted in death, 18 (10.8%) required hospitalization, and 10 (6.0%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NILOTINIB. However, 167 reports have been filed with the FAERS database.
What Other Side Effects Does NILOTINIB Cause?
Death (2,667)
Fatigue (1,679)
Rash (1,250)
Nausea (1,180)
Headache (1,177)
Pain (1,169)
Dyspnoea (1,070)
Diarrhoea (998)
Drug ineffective (992)
Malaise (961)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which NILOTINIB Alternatives Have Lower Therapy non-responder Risk?
NILOTINIB vs NIMESULIDE
NILOTINIB vs NIMODIPINE
NILOTINIB vs NINTEDANIB
NILOTINIB vs NINTEDANIB ESYLATE
NILOTINIB vs NIRAPARIB